EP1 Activators
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-Phenyl-trinor-prostaglandin E2 | 38315-43-4 | sc-201255 sc-201255A | 1 mg 10 mg | $73.00 $587.00 | 5 | |
17-Phenyl-trinor-prostaglandin E2 is a synthetic analogue of prostaglandin E2. It specifically activates the EP1 receptor, a subtype of prostaglandin receptors. Through this activation, it influences various biological processes related to the functioning of the EP1 receptor, which is known to play a role in mediating physiological responses to prostaglandin E2. | ||||||
Misoprostol | 59122-46-2 | sc-201264 sc-201264A sc-201264B | 10 mg 100 mg 1 g | $179.00 $1126.00 $6941.00 | 2 | |
Misoprostol is a synthetic compound that functions as an agonist at various prostaglandin receptors, including EP1. Its activation of the EP1 receptor influences biological pathways associated with prostaglandin E2 signaling, affecting a range of physiological processes through its interaction with these receptors. | ||||||
Sulprostone | 60325-46-4 | sc-201348 sc-201348A | 1 mg 5 mg | $206.00 $592.00 | 8 | |
Sulprostone is a chemical n for its role as an EP1 receptor activator. It engages with the EP1 receptor, which is one of the subtypes of prostaglandin receptors. This interaction facilitates various biological processes linked to prostaglandin E2 signaling, influencing physiological responses in the body related to the activity of these receptors. | ||||||
Latanoprost | 130209-82-4 | sc-201354 sc-201354A sc-201354A-CW | 1 mg 5 mg 5 mg | $58.00 $230.00 $306.00 | 2 | |
Latanoprost is a chemical that acts as an agonist of the EP1 receptor, a specific prostaglandin receptor subtype. This interaction is known to mediate various physiological processes through the prostaglandin signaling pathways, influencing the activity and responses related to prostaglandin E2 receptors. | ||||||
19(R)-hydroxy Prostaglandin E1 | 64625-55-4 | sc-205069 sc-205069A | 50 µg 100 µg | $90.00 $172.00 | ||
19(R)-hydroxy Prostaglandin E1is a chemical that acts as an activator of the EP1 receptor, a specific subtype of prostaglandin receptors. Its interaction with EP1 receptors influences various biological processes through prostaglandin E2 signaling pathways, playing a role in physiological responses associated with these receptor activities. | ||||||
SC 19220 | 19395-87-0 | sc-203450B sc-203450C sc-203450 sc-203450A | 1 mg 5 mg 10 mg 50 mg | $22.00 $104.00 $184.00 $797.00 | 2 | |
SC-19220 is a selective EP1 receptor antagonist rather than an activator. Therefore, it is not included in the subsequent description of EP1 activators. | ||||||
Butaprost | 69685-22-9 | sc-221387 sc-221387A | 500 µg 1 mg | $124.00 $237.00 | 1 | |
A selective EP2 receptor agonist, but its action within the prostaglandin system might have secondary effects on EP1 expression. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $30.00 $142.00 | 16 | |
Prostaglandin E1 (PGE1) is an endogenous prostaglandin that can directly activate EP1. It binds to the EP1 receptor, initiating downstream signaling events. PGE1's activation of EP1 is part of its broader role in various physiological processes, including vasodilation and inhibition of platelet aggregation. PGE1's direct interaction with EP1 highlights its specific role as an endogenous activator of this prostaglandin receptor. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
16,16-Dimethyl PGE2 is a synthetic analog of prostaglandin E2 (PGE2) that can directly activate EP1. It binds to the EP1 receptor, initiating downstream signaling events. This compound's ability to mimic the action of endogenous prostaglandins highlights its role as a chemical activator of EP1, influencing cellular responses associated with prostaglandin signaling pathways. | ||||||
Carboprost Tromethanimine | 58551-69-2 | sc-504637 | 1 mg | $300.00 | ||
This synthetic analog of prostaglandin F2α may alter EP1 expression by modulating the overall prostaglandin receptor dynamics. | ||||||